AstraZeneca to build $1.5-bln cancer drug plant in Singapore
AstraZeneca plans to build a $1.5 billion manufacturing facility in Singapore to produce a promising category of cancer-killing drugs called antibody-drug conjugates (ADCs), the Anglo-Swedish drugmaker said on Monday. The facility, which will be the drugmaker’s first end-to-end ADC production site, will be supported by the Singapore Economic Development Board. The company did not provide […]
Read More
